Go offline with the Player FM app!
Episode 359: Journal Club- Aflibercept vs Bevacizumab, Gas Tamponade for Postoperative Vitreous Hemorrhage Prevention, and Post-Macular Hole Surgery Patient Positioning
Manage episode 340556298 series 1302113
Drs. Shriji Patel, Safa Rahmani, and Sarwar Zahid join for a journal club discussion of three recent publications in major ophthalmology journals:
Aflibercept or Bevacizumab First for Diabetic Macular Edema (https://www.nejm.org/doi/full/10.1056/NEJMoa2204225)
Gas Tamponade for Postoperative Vitreous Hemorrhage Prevention (https://www.ajo.com/article/S0002-9394(22)00251-3/fulltext)
Positioning after Macular Hole Surgery (https://ophthalmologyretina.org/article/S2468-6530(22)00322-0/fulltext)
Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, DORC, Genentech, and Regeneron. Drs. Patel, Rahmani, and Zahid have no relevant disclosures.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi
332 episodes
Manage episode 340556298 series 1302113
Drs. Shriji Patel, Safa Rahmani, and Sarwar Zahid join for a journal club discussion of three recent publications in major ophthalmology journals:
Aflibercept or Bevacizumab First for Diabetic Macular Edema (https://www.nejm.org/doi/full/10.1056/NEJMoa2204225)
Gas Tamponade for Postoperative Vitreous Hemorrhage Prevention (https://www.ajo.com/article/S0002-9394(22)00251-3/fulltext)
Positioning after Macular Hole Surgery (https://ophthalmologyretina.org/article/S2468-6530(22)00322-0/fulltext)
Relevant Financial Disclosures: Dr. Sridhar is a consultant for Alcon, DORC, Genentech, and Regeneron. Drs. Patel, Rahmani, and Zahid have no relevant disclosures.You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi
332 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.